John Koster and Eric Larsen Join 2Morrow’s Board of Directors

2Morrow Recruits Past CEO of Providence and UW EIR to Join its Board

Kirkland, WASHINGTON – October 17, 2016 -- 2Morrow, Inc. announced that John Koster, MD, former CEO of Providence Health, and Eric Larsen, Entrepreneur in Residence at the University of Washington CoMotion, have joined 2Morrow’s board of directors. 

Dr. John Koster served as CEO of Providence Health & Services for ten years. Prior, Koster held several leadership positions at health insurance plans, hospital systems, medical group, and consulting practices. He advises hospital systems, health insurers, boards and healthcare technology companies. Dr. Koster is an internist and emergency medicine physician. He is an author and also serves on the board of Banner Health and Sutter Health.  

Eric Larsen serves as an Entrepreneur in Residence with the University of Washington’s CoMotion office. An experienced entrepreneur, Larsen works with emerging Northwest companies seeking to scale by leveraging his broad experience in engineering, technology, finance, and business operations. He advises several companies and is an angel investor who has led multiple fund raising rounds. Previously, Larsen held several senior leadership positions at Quellos and BlackRock.  

“2Morrow is extremely honored to have John Koster and Eric Larsen join our board,” says Brandon Masterson, CEO of 2Morrow, Inc. “John brings extensive experience in the healthcare provider and insurer space that will help guide our strategy as we serve those markets. His passion for creating systems that treat the individual is in solid alignment with 2Morrow’s values. Eric’s proven record in helping startups scale and create value will be invaluable as we move forward and grow 2Morrow as a Digital Health leader.”

2Morrow is a Seattle area digital health company who offers evidence-based behavior change programs to states, health plans, employers and wellness program. The addition of Koster and Larsen to the board provides 2Morrow with exert advisors that understand healthcare, startups, digital health and growth industry.  The company is well positioned as an early leader in the mHealth space with the launch of its clinically-tested smoking cessation program SmartQuit® and the some to be released programs for weight and stress. This month 2Morrow was named one of the Top 15 Patient Engagement Startups by Med City News. /
About 2Morrow®

2Morrow, Inc. is a digital health company dedicated to improving millions of lives with the use of evidence-based, behavior change programs delivered via the smartphone (mhealth). We distribute our programs through employers, states, wellness programs and health plans. SmartQuit® is the first clinically tested smoking cessation app shown to help smokers quit. It was built in collaboration with the Fred Hutch Cancer Research center and is powered by 2Morrow’s behavior change.